The risk of central inflammation is higher for COVID infections than for the vaccine

It is estimated that four million more people suffer from prolonged COVID, which has symptoms such as mental confusion, persistent cough, fatigue, etc. A new study published this week found that one in 20 people who have had COVID-19 report still having symptoms six to 18 months after first getting sick.

Another threat after a COVID-19 infection is myocarditis, or inflammation of the central muscle. Inflammation can decrease the center’s ability to pump blood and cause chest pain, shortness of breath, and immediate or abnormal central heartbeat, also known as arrhythmias. A study published Wednesday in the journal Frontiers in Cardiovascular Medicine found that the risk of developing myocarditis is seven times higher with a COVID-19 infection than with the COVID-19 vaccine. It also finds that the risk of myocarditis is 15 times higher in COVID-19 patients, regardless of vaccination status.

[Related: How Harmful Is Myocarditis? The fact about the condition. ]

“Our effects show that the threat of myocarditis from being inflamed with COVID-19 is far greater than receiving the vaccine,” Navya Voleti, a resident physician in Penn State’s Department of Medicine, said in a statement. “In the future, we will be monitoring for possible long-term effects on those who spread myocarditis. “

A team from Penn State College of Medicine reviewed research from 22 foreign studies published between December 2019 and May 2022. The studies involved only about 58 million patients, all of whom reported problems at the center.

Patients were in either the vaccinated organization or the COVID-19 organization. The vaccination organization included 55. 5 million other people vaccinated against COVID-19 compared to those who were not vaccinated. The COVID-19 organization included the 2. 5 million who virus compared to those who did not.

Within the vaccination group, the researchers separately compared the risk of myocarditis for COVID-19 vaccines, adding mRNA vaccines (Pfizer, Moderna), Novavax, AstraZeneca, and Johnson and Johnson.

[Related: What you want to know about central inflammation and COVID-19 vaccines. ]

Among those diagnosed with myocarditis after receiving the vaccine or having COVID-19, the majority (61%) were men. Of the patients diagnosed with myocarditis in the vaccination and COVID-19 groups, 1. 07% were hospitalized and 0. 015% died.

“COVID-19 infection and related vaccines pose a threat of myocarditis. However, the relative threat of central inflammation induced by COVID-19 infection is particularly greater than the threat posed by vaccines,” said Paddy Ssentongo, resident physician at Penn State Department of Medicine statement and leader of the study. “We hope our findings will help alleviate vaccine hesitancy and increase vaccine acceptance. “

The findings come after claims on social media that the vaccine causes irreversible cases of myocarditis. Although heart headaches after an mRNA vaccine are a rare side effect of COVID-19 mRNA vaccination, most healthcare professionals agree that the risk of getting vaccinated outweighs the risks. .

The articles may include associated links that allow us to obtain a percentage of profit from any purchase made.

Registration or use thereof constitutes acceptance of our terms of use.

© 2022 Recurring. All rights reserved.

Leave a Comment

Your email address will not be published. Required fields are marked *